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Abstract
Introduction: Small cell lung carcinoma frequently metastasizes to lymph nodes, liver, adrenal glands, bone, brain
and pleura. Metastasis of small cell lung cancer to the thyroid gland is extremely rare.
Case presentation: A 55-year-old Turkish man presented with a mediastinal mass intermingled with mediastinal
lymphadenopathy, measuring 11cm in total, and encasing superior vena cava and deviating his trachea, esophagus
and vascular structures. He had superior vena cava syndrome. His thyroid appeared normal on computed tomography
of his chest. A bronchoscopic biopsy showed small cell lung carcinoma. Chemotherapy with cisplatin and etoposide
and external radiotherapy was given. Six months after the presentation, multiple brain metastases were detected on
magnetic resonance imaging. Chemotherapy was changed to topotecan and cranial irradiation was performed. At the
same time, a right thyroid nodule was detected on computed tomography of his chest and showed growth in size in
the following 4 months. A palpable right thyroid nodule came to our attention at that time, the 10th month of
presentation. Free thyroxine, free triiodothyronine, thyroid-stimulating hormone, antithyroglobulin and antithyroid
peroxidase antibodies were within normal limits. Thyroid ultrasonography showed a right thyroid lobe 26.2×16.8×15.7mm
hypoechoic solid nodule with irregular borders. Ultrasonography-guided thyroid fine-needle aspiration biopsy showed
metastasis from small cell lung carcinoma. His cranial metastases worsened. He developed right cervical lymph node,
hepatic, pancreatic and meningeal metastases and died 15 months after the initial presentation and 9 months after the
detection of thyroid metastasis by computed tomography of his chest. Our case and two previously reported cases were
male, 55-years old or older and had history of more than 40 pack-years of cigarette smoking. All had metastatic disease
elsewhere, when the thyroid metastasis was diagnosed by fine-needle aspiration biopsy. All had poor survival, between
9 and 18 months, after thyroid metastasis was diagnosed.
Conclusions: We conclude that in a patient with a known history of malignant disease, the finding of a new thyroid
mass should be promptly evaluated with a thyroid fine-needle aspiration biopsy to search for metastatic disease. The
clinical features of our and two previously reported cases were summarized.
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Introduction
Although the thyroid gland has a rich vascular supply,
carcinomas rarely metastasize to the thyroid [1]. The
primary carcinomas that metastasize to the thyroid are
renal cell (48.1%), colorectal (10.4%), lung (8.3%) and
breast (7.8%) carcinomas, melanoma (4%), sarcoma (4%)
and other types (17.4%) [2]. Among the lung carcinomas
metastasizing to the thyroid, adenocarcinomas are the
commonest followed by squamous cell carcinomas [1–5].
Small cell and large cell carcinomas rarely metastasize to
the thyroid gland [6–8]. Small cell lung cancer is a rapidly
progressive malignancy with a poor survival rate. Small
cell lung cancers frequently metastasize to lymph nodes,
liver, adrenal glands, bone, brain and pleura. Metastasis of
small cell lung cancer to the thyroid is a very rare clinical
encounter [6, 7]. We report a case of small cell lung car-
cinoma that metastasized to the thyroid gland and review
the clinical literature.
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Case presentation
A 55-year-old Turkish man presented with swelling in
the anterior of his neck and dyspnea for 3 to 4 days. His
past medical history was significant for hypertension,
hyperlipidemia and a hip prosthesis. He was treated with
atenolol, quinapril-hydrochlorothiazide combination and
atorvastatin tablets. He had a 50-pack year history of
cigarette smoking. His blood pressure was 140/88mmHg,
pulse 96 beats per minute and respiratory rate 16 per
minute. A chest X-ray showed a mediastinal mass.
Computed tomography (CT) of his thorax showed a
10.6×9.7×10.8cm mediastinal mass encasing superior vena
cava, causing stenosis of the lumen and deviation of his
trachea, esophagus and vascular structures. The mass also
reached to the right pulmonary hilus. The presence of
lymph node metastasis was not clearly discernible from
the images, because the mass appeared somewhat homo-
geneous (Fig. 1). Subcarinal lymphadenopathy was evident
(Fig. 2). In retrospect, we think that the mass was inter-
mingled with multiple lymph node metastases, because
they regressed with chemotherapy and radiotherapy. The
thyroid appeared normal on CT of his chest. He exhibited
clinical features of superior vena cava syndrome. The staging
was done by CT of his chest and abdomen. Positron
emission tomography-CT and endobronchial ultrasound
were not performed. There was no evidence of liver or
pancreatic metastases on the initial CT of his abdomen.
He had a 15mm hypodense nodule in his left adrenal
gland that was not biopsied and remained stable in size
during follow-up. A bronchoscopic biopsy showed small
cell carcinoma of the lung (Fig. 3). Immunohistochemical
staining with synaptophysin, pan cytokeratin and chromo-
granin (Fig. 4) were positive. A diagnosis of limited stage
small cell lung carcinoma was made and he was started
on chemotherapy with cisplatin and etoposide. When his
tumor diminished in size and fitted to the radiotherapy
field, external radiotherapy was instituted. The clinical
course showed refractoriness to treatment. He developed
radiation pneumonitis and later fibrosis in his right lung.
Six months after the presentation, a right thyroid nodule
was detected on CT of his chest and multiple brain metas-
tases were detected on magnetic resonance imaging of his
brain. Chemotherapy was changed to topotecan. Cranial
irradiation was given. He developed pancytopenia. Ten
months after the presentation, the patient’s oncologist
(second author Gülistan Köksal, MD) was alerted by the
finding of the size progression of the right thyroid nodule
on a CT scan of the patient’s chest (Fig. 5). On physical
examination, a right thyroid nodule was palpable. Thyroid
function tests were within normal limits at that time, as
well as antithyroglobulin and antithyroid peroxidase anti-
bodies, which were performed at a later date. Tests
Fig. 1 Computed tomography image of the mediastinal mass
intermingled with mediastinal lymphadenopathy
Fig. 2 Computed tomography image of subcarinal lymphadenopathy
Fig. 3 Oil immersion, high power (×1000 magnification) hematoxylin
and eosin staining of bronchial biopsy. Small cell carcinoma cells are
seen in the lamina propria juxtaposed to red blood cells. Small cell
carcinoma cells are characterized by hyperchromatic nuclei, high nuclear
to cytoplasmic ratio and nuclear molding
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revealed: free thyroxine (T4) 1.32ng/ml (normal range 0.8
to 1.81), free triiodothyronine (T3) 2.35pg/ml (normal
range 2.30 to 4.40), thyroid-stimulating hormone
0.313μIU/ml (normal range 0.27 to 4.20), antithyroid per-
oxidase antibody 1.1IU/ml (normal range <12), and
antithyroglobulin antibody 5.9IU/ml (normal range <34).
Thyroid ultrasonography showed a 26.2×16.8×15.7mm
hypoechoic solid nodule with irregular borders in his right
thyroid lobe (Fig. 6). An ultrasonography-guided thyroid
fine-needle aspiration biopsy showed metastasis from
small cell lung carcinoma (Fig. 7). His cranial metastases
worsened. There was no size reduction of the initially de-
tected metastatic thyroid nodule and two new hypoechoic
nodules of 4.2×4.7×2.5mm and 4.2×3.4×3.4mm with
blurred borders were detected by thyroid ultrasonography
performed 4.5 months after the diagnosis of the thyroid
metastasis by fine-needle aspiration biopsy. He developed
right cervical lymph node, hepatic, pancreatic and
meningeal metastases and expired 15 months after the ini-
tial presentation and 9 months after the detection of thy-
roid metastasis on CT of his chest.
Discussion
The clinical detection of thyroid metastasis from nonthyroid
primary tumors is an extremely rare event, but aut-
opsy series report somewhat higher rates. In a post-
mortem study performed on patients who died of
advanced cancer, the rate of metastasis to the thyroid
gland was 8.6% [9]. A meticulous autopsy study (Ref-
erence [10] could not be located in PubMed, Scopus,
Science Direct and Turkish Academic Network and
Information Center and was cross-referred from refer-
ence [11]) that microscopically examined at least one
Fig. 4 Immunohistochemical (×400 magnification) chromogranin
staining (brown) as a marker for neuroendocrine differentiation
in bronchial biopsy
Fig. 5 Computed tomography image of the thyroid gland and right
thyroid nodule
Fig. 6 Thyroid ultrasonography image of right thyroid lobe
Fig. 7 Oil immersion, high power (×1000 magnification)
Diff-Quick staining of thyroid fine-needle aspiration biopsy. Small
cell carcinoma cells are characterized by hyperchromatic nuclei, coarse
chromatin, salt and pepper appearance, high nuclear to cytoplasmic
ratio and nuclear membrane irregularities. No thyroid follicular cells are
seen. Small cell carcinoma cells are much larger than thyroid
follicular cells
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slice of thyroid for every 5 gram of tissue in patients
who died of metastatic cancer reported the rate of
thyroid metastasis as 24.2% [10, 11]. The clinical find-
ing of thyroid metastasis from a nonthyroid primary
tumor is much less common, although the incidence
depends on how vigorously this is sought. Thyroid
metastasis of nonthyroid primary cancers represented
0.16% of all thyroid fine-needle aspiration biopsies
and 1.9% of all thyroid fine-needle aspiration biopsies
that were categorized as malignant in a multicenter
study from the USA and Europe [1]. In an analysis of thy-
roidectomy specimens performed on patients with a soli-
tary thyroid metastasis (patients with multiple metastases
to other sites were excluded), Calzolari et al. reported the
prevalence of intrathyroid metastasis as 0.15% [12]. Chung
et al. reviewed secondary thyroid tumors reported between
2000 and 2010, and concluded that among the 293 patients
with adequate data, 60% of cases had extrathyroid metasta-
ses, either diagnosed previously or concomitantly with thy-
roid metastasis [2]. Up to 40% of metastases were solitary
to the thyroid gland and presented as isolated thyroid me-
tastasis [2]. In only 20% of the cases were the diagnosis of
nonthyroid primary cancer and the detection of thyroid
metastases concurrent [2]. There are only a few reported
cases of thyroid metastasis from small cell lung cancer
[6, 7]. Therefore, we decided to report this particular
case and review similar cases in the clinical literature.
Our literature review focused on articles published in
the English language and excluded autopsy series and a
case reported earlier in another language [13].
We only found two previous reports of small cell lung
cancer metastasis to the thyroid [6, 7]. The clinical fea-
tures of those and our case are summarized in Table 1.
All the patients with thyroid metastasis of small cell lung
cancer were male and were 55-years old or older. All
had a history of heavy cigarette smoking. All had exten-
sive stage disease when thyroid metastasis was diag-
nosed. The two previously reported patients had
synchronous metastasis to the thyroid gland. Our case
had metachronous detection of thyroid metastasis. In
patients with metachronous metastases, the mean inter-
val for detection of thyroid metastasis from primary tu-
mors was 68 months for renal cell cancer, 48 months for
breast cancer, 42 months for colorectal cancer and 21
months for malignant melanoma [2]. The time period
between the diagnosis of primary tumor and the discov-
ery of thyroid metastasis was shortest in patients with
lung cancer, with a mean of 4.5 months [2]. In our pa-
tient, thyroid metastasis appeared 6 months after the
presentation.
Our patient was euthyroid without evidence of auto-
immune thyroid disease. Ozgu et al. reported the coex-
istence of toxic multinodular goiter and thyroid
metastasis from small cell lung cancer in a patient with
thyrotoxicosis [6]. Primary nonthyroid tumors may also
cause thyrotoxicosis due to massive metastasis causing
destructive thyroiditis [14].
In all three reported patients with thyroid metastasis
of small cell lung cancer, the diagnosis was established
by thyroid fine-needle aspiration biopsy (Table 1). In
Table 1 Clinical features of the current and previously reported* cases of small cell lung carcinoma with thyroid metastasis
Author, year, reference Ozgu et al. 2012 [6] Katsenos et al. 2013 [7] Can and Köksal 2015 (this report)
Gender Male Male Male
Age (years) 66 55 55
Comorbidities CAD, CABG CAD, PTCA, DM HTN, HL, hip prosthesis
Smoking history 75 pack-year 40 pack-year 50 pack-year
Thyroid status Hyperthyroid due to toxic
MNG
Euthyroid† Euthyroid
Other sites of metastasis‡ Adrenal mets Cervical and mediastinal LN, cerebellar
mets
Cerebral mets
Synchronicity Synchronous Synchronous Metachronous
Time to detection of metastasis NA NA 6 months
Diagnosis of thyroid metastasis FNA FNA FNA
Thyroidectomy No No No
Treatment Chemotherapy Chemotherapy, cranial irradiation Chemotherapy, lung and cranial
irradiation
Survival after diagnosis of thyroid
metastasis
11 months 18 months† 9 months
CABG coronary artery bypass grafting, CAD coronary artery disease, DM diabetes mellitus, FNA fine-needle aspiration biopsy of the thyroid, HL hyperlipidemia, HTN
hypertension, LN lymph nodes, mets metastasis, MNG multinodular goiter, NA nonapplicable because of synchronous diagnosis of the small cell lung cancer and
thyroid metastasis, PTCA percutaneous transluminal coronary angioplasty, *Literature review was based on clinical cases (not autopsies) and to articles published
in the English language †personal e-mail communication with Stamatis Katsenos, MD, PhD on 16 November 2014, ‡represents other sites of metastasis when
thyroid metastasis was diagnosed
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their recent review of thyroid metastases from nonthyroid
malignancies, Chung et al. estimated that thyroid
fine-needle aspiration biopsy provided the correct diag-
nosis in 73.7% of patients [2]. Pusztaszeri et al. reported
that thyroid fine-needle aspiration biopsy categorized 87%
of thyroid metastasis of nonthyroid primary carcinomas to
malignant or to the suspicious for follicular neoplasm
group, the categories that call for surgical intervention as
the treatment approach [1]. These sensitivity rates for
secondary carcinomas are similar to the sensitivity rate of 83%
(range 65 to 98%) for thyroid fine-needle aspiration biopsy for
detection of primary carcinomas in thyroid nodules [15].
The difficulty of distinguishing primary thyroid anaplastic
carcinoma or poorly differentiated thyroid carcinoma from
metastatic high-grade malignancy is reported to be a source
of error for accurate cytological interpretation in the
evaluation of secondary thyroid tumors [1, 5].
None of the cases of thyroid metastasis from small cell
lung carcinoma underwent thyroidectomy (Table 1). All
were treated with chemotherapy consisting of cisplatin
and etoposide or chemotherapy and radiotherapy. Sur-
gery was not considered in our case, because there were
cerebral metastases and surgical excision is not a recom-
mended modality in the management of small cell lung
carcinoma. Osawa et al. reported the case of a 67-year-
old man diagnosed with stage IIIA (T2N2M0) small cell
lung cancer who was treated with cisplatin and etopo-
side followed by cranial irradiation [8]. Four years later,
an isolated thyroid metastasis was diagnosed. A thyroid
metastasectomy showed large cell carcinoma. Review of
the initial lung material showed both small and large
cells in the tumor. The authors concluded that the pa-
tient had a combined small and large cell carcinoma in
his lung as the primary, and the large cell component
metastasized to the thyroid gland [8]. As the large cell
carcinoma component metastasized to the thyroid, we
did not include this case in Table 1.
The appearance of thyroid metastasis is thought to in-
dicate a poor prognosis. Earlier case reports or series
presented the average survival from diagnosis to death
as 2 months in lung carcinomas with thyroid metastasis
[4, 11]. The survival of the recently reported patients in
2012 and 2013 and our patient ranged between 9 and 18
months (Table 1 and personal e-mail communication
with Stamatis Katsenos, MD, PhD on 16 November 2014)
and probably reflects the effect of improved treatment
modalities in the last few years compared to previous
decades. From a case series of 25 patients with solitary
intrathyroid metastasis, Calzolari et al. reported that pa-
tients with a single metastatic lesion on the thyroid from a
nonthyroid primary carcinoma had better survival than
those with multiple metastases to the thyroid [12].
The incidence of primary thyroid cancer is on the rise
[16], but it is not known if the incidence of thyroid
metastases from nonthyroid malignancies is also on the
rise. There is an increase in the number of case reports
of nonthyroid primary cancer metastasis to the thyroid
gland. From the Mayo Clinic, only two cases of thyroid
metastasis from nonthyroid primary cancers were ob-
served in thyroid surgeries performed between 1892 and
1932 [17], 14 cases were reported from the preceding
55-year period in 1964 [17], 12 cases during the preced-
ing 21-year period in 1982 [18], 15 cases during the pre-
ceding 6-year period in 1987 [19], and 39 cases in the
preceding 10-year period in 1997 [5]. The upper limit of
the preceding years ended a few years earlier than the
publication dates of the Mayo Clinic reports. In 2010,
Chung et al. reported 372 cases of thyroid metastases of
nonthyroid malignancies and pointed out that there is
an apparent increase in the number of reported cases of
thyroid metastasis from nonthyroid primary tumors [2].
This observed increase can be attributed to the growth
of the population [20] resulting in an increasing number
of cases of cancer and thus metastasis, an increase in the
number of journals facilitating publication [21] or an in-
crease in the incidence of nonthyroid cancer [22]. In-
creasing use of imaging technologies, such as positron
emission tomography, more frequent use of thyroid fine-
needle aspiration biopsy and improved survival of pa-
tients with disseminated cancer probably contributed to
the increased number of case reports of thyroid metasta-
sis from nonthyroid primary carcinomas [1, 2].
Primary small cell carcinomas originating from the
urinary bladder [23] and uterine cervix [24] have also been
reported to metastasize to the thyroid gland. Primary
small cell carcinoma of the thyroid is a very rare entity
[25]. After the introduction of immunohistochemistry,
some of the previously diagnosed primary small cell
carcinomas of the thyroid were diagnosed as primary
lymphomas, poorly differentiated insular carcinomas of
the thyroid or small cell variants of medullary carcinomas
[25]. A variety of neuroendocrine tumors have also been
reported to metastasize to the thyroid [26].
In view of our clinical experience of this reported
case, we suggest that the finding of a new thyroid nod-
ule in a patient with a known malignancy should trigger
a search for metastasis. Secondary thyroid tumors after
a nonthyroid primary tumor are rare. Ultrasonography-
guided thyroid fine-needle aspiration biopsy aids in the
diagnosis and helps to differentiate whether the nodule in
question is a benign thyroid nodule, a primary thyroid
carcinoma or metastatic thyroid carcinoma.
Conclusions
We report a rare case of thyroid metastasis from small
cell lung carcinoma. After reviewing previously reported
cases [6, 7] and our case, we conclude that the appear-
ance of a thyroid nodule during follow-up of patients
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with a prior history of malignancy should be promptly
evaluated with a thyroid fine-needle aspiration biopsy to
search for metastatic disease.
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